Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.92
-0.12 (-1.99%)
Feb 5, 2026, 11:56 AM EST - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $882.41 million as of February 5, 2026. Its market cap has increased by 98.52% in one year.
Market Cap
882.41M
Enterprise Value
738.51M
1-Year Change
98.52%
Ranking
Category
Stock Price
$5.92
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $882.41M, an increase of 37.98%. That is a compound annual growth rate of 5.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 900.30M | 20.32% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 1.03B |
| Theravance Biopharma | 1.01B |
| ARS Pharmaceuticals | 1.00B |
| Ventyx Biosciences | 1.00B |
| GH Research | 987.51M |
| Geron | 963.92M |
| BridgeBio Oncology Therapeutics | 950.27M |
| Palvella Therapeutics | 945.85M |